The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 429
QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes
Wenzel-Seifert, K., Wittmann, M., & Haen, E. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0687 · Cited by 256
Indik, J. H., Pearson, E. C., Fried, K., & Woosley, R. L. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.05.023 · Cited by 166
The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance
Darpö, B. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00487.x · Cited by 141
Assessment of prolonged QT and JT intervals in ventricular conduction defects
Rautaharju, P. M., Zhang, Z.-M., Prineas, R., & HEISS, G. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.055 · Cited by 135
Zhang, Y., Post, W. S., Dalal, D., Blasco‐Colmenares, E., Tomaselli, G. F., & Güallar, E. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.433 · Cited by 130
Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs
Vieweg, W. V. R., Wood, M. A., Fernandez, A., Beatty-Brooks, M., Hasnain, M., & Pandurangi, A. K. (2009) · Drugs & Aging · doi:10.2165/11318880-000000000-00000 · Cited by 110
Self-citationCardiac Safety of Citalopram: Prospective Trials and Retrospective Analyses
Rasmussen, S. L., Overø, K. F., & Tanghøj, P. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00004 · Cited by 103
Cited by
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Self-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Citalopram has been associated with prolonged QTc interval at high doses but clinical relevance is unclear (Vieweg et al., 2012).”
BackgroundBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Beach, S. R., Celano, C. M., Noseworthy, P. A., Januzzi, J. L., & Huffman, J. C. (2013) · Psychosomatics · doi:10.1016/j.psym.2012.11.001 · Cited by 345
A Comparison of the Risk of QT Prolongation Among SSRIs
Funk, K. A., & Bostwick, J. R. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013501994 · Cited by 174
Metadata
- Authors
- Vieweg, W. V. R., Hasnain, M., Howland, R. H., Hettema, J. M., Kogut, C., Wood, M. A., & Pandurangi, A. K.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 125
- Issue
- 9
- Pages
- 859-868
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2088722048
- Cited by
- 270
- References
- 27
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling? https://app.cochat.ai/papers/10.1016/j.amjmed.2011.12.002
- The paper
- Vieweg, W. V. R., Hasnain, M., Howland, R. H., Hettema, J. M., Kogut, C., Wood, M. A., & Pandurangi, A. K. (2012). Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling? The American Journal of Medicine. https://doi.org/10.1016/j.amjmed.2011.12.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.